...
首页> 外文期刊>Internal medicine. >Pulmonary Tumor Thrombotic Microangiopathy Caused by Urothelial Carcinoma Expressing Vascular Endothelial Growth Factor, Platelet-derived Growth Factor, and Osteopontin
【24h】

Pulmonary Tumor Thrombotic Microangiopathy Caused by Urothelial Carcinoma Expressing Vascular Endothelial Growth Factor, Platelet-derived Growth Factor, and Osteopontin

机译:表达血管内皮生长因子,血小板衍生生长因子和骨桥蛋白的尿路上皮癌引起的肺肿瘤血栓性微血管病

获取原文
获取原文并翻译 | 示例

摘要

Pulmonary tumor thrombotic microangiopathy (PTTM) is a fatal cancer-related pulmonary complication. It is generally caused by gastric adenocarcinoma, and several molecules produced by tumor cells are reported to play important roles in its pathogenesis. We herein report an autopsy case of PTTM caused by urothelial carcinoma. Vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), and osteopontin were found to be expressed in both the primary tumor cells and metastatic cells in the PTTM lesions. These findings implicate the possible involvement of VEGF, PDGF, and osteopontin in the pathogenesis of PTTM caused by urothelial carcinoma.
机译:肺肿瘤血栓性微血管病(PTTM)是一种致命的癌症相关的肺部并发症。它通常是由胃腺癌引起的,据报道,肿瘤细胞产生的几种分子在其发病机理中起着重要作用。我们在这里报告由尿路上皮癌引起的PTTM尸检病例。发现血管内皮生长因子(VEGF),血小板衍生生长因子(PDGF)和骨桥蛋白在PTTM病变的原发肿瘤细胞和转移细胞中均有表达。这些发现暗示VEGF,PDGF和骨桥蛋白可能参与了由尿路上皮癌引起的PTTM的发病机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号